Home › NDC Lookup › RxCUI directory › RxCUI 198322

Trifluoperazine 1 MG Oral Tablet — RxCUI 198322

RxNorm drug concept · Semantic clinical drug
RxCUI 198322 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198322
Official nameTrifluoperazine 1 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astrifluoperazine (as trifluoperazine hydrochloride) 1 MG Oral Tablet; trifluoperazine HCl 1 MG Oral Tablet
FDA products mapped17
Package NDCs mapped17
Reported Medicaid activity (SDUD)7,503 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trifluoperazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is used to manage schizophrenia. It can also be used for short-term treatment of generalized non-psychotic anxiety, though it is usually not the first medicine tried for that.
  • The label limits anxiety treatment to no more than 12 weeks and to a low daily dose ceiling. Longer or higher use can cause tardive dyskinesia that may be permanent. Your prescribe...
  • Drowsiness, dizziness, dry mouth, blurred vision, fatigue and trouble sleeping are common. Be careful with driving early on. Rhythmic movements of the mouth or tongue, stiff muscle...
  • It is best to avoid it. Alcohol, sedatives and narcotics can add to the drowsiness and depressant effects of this medicine.
📖 Read our full Trifluoperazine guide →

🕸️ Concept Web — How Trifluoperazine 1 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trifluoperazine 1 MG Oral Tablet RxCUI 198322

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Trifluoperazine 10800
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trifluoperazine Oral Tablet 374208
    • Trifluoperazine Oral Product 1158789
    • Trifluoperazine Pill 1158790
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Trifluoperazine 1 MG 328789

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trifluoperazine 1 MG SCDC · 328789
  • Trifluoperazine Oral Tablet SCDF · 374208
  • Trifluoperazine Oral Product SCDG · 1158789
  • Trifluoperazine Pill SCDG · 1158790

📦 FDA Products & Package NDCs

17 products · 17 package NDCs
17 package NDCs map to RxCUI 198322 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-2401-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2401-01) Trifluoperazine Hydrochloride Mylan Pharmaceuticals Inc. 1997-08-29
00378-2402-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2402-01) Trifluoperazine Hydrochloride Mylan Pharmaceuticals Inc. 1997-08-29
00378-2405-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2405-01) Trifluoperazine Hydrochloride Mylan Pharmaceuticals Inc. 1997-08-29
00378-2410-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-2410-01) Trifluoperazine Hydrochloride Mylan Pharmaceuticals Inc. 1997-08-29
00781-8028-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8028-01) Trifluoperazine Hydrochloride Sandoz Inc. 2019-01-14
00781-8032-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8032-01) Trifluoperazine Hydrochloride Sandoz Inc. 2019-01-14
00781-8034-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8034-01) Trifluoperazine Hydrochloride Sandoz Inc. 2019-01-14
00781-8036-01 100 TABLET, FILM COATED in 1 BOTTLE (0781-8036-01) Trifluoperazine Hydrochloride Sandoz Inc. 2019-01-14
48433-0140-20 100 BLISTER PACK in 1 CARTON (48433-140-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Safecor Health LLC 2026-04-07
48433-0141-20 100 BLISTER PACK in 1 CARTON (48433-141-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Safecor Health LLC 2026-04-07
48433-0142-20 100 BLISTER PACK in 1 CARTON (48433-142-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Safecor Health LLC 2026-04-07
48433-0143-20 100 BLISTER PACK in 1 CARTON (48433-143-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Safecor Health LLC 2026-04-07
51079-0572-20 100 BLISTER PACK in 1 CARTON (51079-572-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Mylan Institutional Inc. 1998-03-04
51079-0573-20 100 BLISTER PACK in 1 CARTON (51079-573-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Mylan Institutional Inc. 1998-03-04
51079-0574-20 100 BLISTER PACK in 1 CARTON (51079-574-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Mylan Institutional Inc. 1998-03-04
51079-0575-20 100 BLISTER PACK in 1 CARTON (51079-575-20) / 1 TABLET, FIL... Trifluoperazine Hydrochloride Mylan Institutional Inc. 1998-03-04
72162-2204-01 100 TABLET, FILM COATED in 1 BOTTLE (72162-2204-1) Trifluoperazine Hydrochloride Bryant Ranch Prepack 2024-04-02
Observed labelers: Mylan Institutional Inc. (4) · Mylan Pharmaceuticals Inc. (4) · Safecor Health LLC (4) · Sandoz Inc. (4) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.